Germagic: Tackling Challenges of the COVID-19 Pandemic

The key objective of this case is to review an innovative product's supply chain, so as to identify its supply risks and to improve its supply chain resilience. When COVID-19 caught the world off guard in early 2020, Germagic Biochemical Technology (HK) Ltd. (GBT) was ready to introduce its disinfectant products that demonstrated long-lasting properties to eliminate more than 99% of infectious viruses and bacteria. Through testing and certification from different government authorities and health bureaus, the protagonist of this case, Hamilton Hung, co-founder of GBT has been working with partnering firms to build international recognition while exploring the export market. As a family run industrial business, Chiaphua Industries Ltd. faces many challenges in promoting Germagic products. Without global uniform standards and protocols in long-lasting disinfectant products, some customers are skeptical about their effectiveness. Exploiting the market need, different suppliers have flooded the market with certain products that are less effective than what they claim, while COVID-19 continues its devastation for the foreseeable future. On the flip side, it is also possible that COVID-19 may just disappear like many previous pandemics in human history, and that will cause a big drop in demand of such products. Facing all these challenges and market uncertainties, how could GBT expand into the local and regional markets by creating a more forward-looking, resilient supply chain that allows the company to stay ahead of its competitors? And how can it improve the distribution channels to promote customer products?

• Technology and analytics
• Innovation
• Risk management
• Manufacturing strategy
• Supply chain management
• Strategy
• Sales and marketing
• Business ethics